Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...
“It fell into this trap where it would try to load all ... the SOLiD or Illumina [machines].” Just as combining computational strategies will be essential to dealing with sequencing data ...
Next-generation sequencing (NGS) technology, which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When the ...
23h
Hosted on MSNHow Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff warChina has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
China’s Commerce Ministry this week said it placed Illumina, the leading maker of next-generation sequencing machines, on its list of “unreliable entities,” part of China’s retaliation ...
After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...
Hosted on MSN1mon
Illumina Deal Sends 10x Genomics Stock TumblingShares of 10x Genomics, which specializes in tools that allow scientists to precisely analyze the genes of a single cell at a time, were falling fast on Wednesday after a small competitor got ...
Following the Jan. 13 announcement, Illumina shares jumped 5.5% to close at $144.22 on Monday. The company has democratized sequencing over the past 20 years, and with the progress in AI and ...
Over the last six months, ANGLE has overcome technical issues to successfully use Illumina assays, coupled with their next generation sequencing (NGS) platform, to provide a complete solution for the ...
DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company Truveta to create the largest and most diverse database of genetic information in the ...
More than 60 per cent of the world’s genetic sequencing data is generated by Illumina’s machines. After being blacklisted by Beijing, the company’s stock price fell 5 per cent. 02:52 China ...
Over the last six months, Angle has overcome technical issues to successfully use Illumina assays, coupled with their next generation sequencing (NGS) platform, to provide a complete solution for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results